38.83EUR+0.23%Mkt Cap: 8.69B $P/E: 22.791d ago
Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide. The company offers sample technology consumables, such as nucleic acid stabilization and purification …
Industry Peers
Diagnostics & ResearchKey Statistics
Company
Market Cap8.69B $
Enterprise Value9.20B $
Revenue (TTM)2.28B $
Gross Profit1.41B $
Net Income (TTM)461.83M $
Revenue/Share11.35 USD
Last Price38.83 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees5.5K
CountryDE
SectorHealthcare
IndustryDiagnostics & Research
ISINNL0012169213
Valuation
P/E (Trailing)22.79
P/E (Forward)16.45
PEG1.08
EV/EBITDA11.53
EV/Revenue4.03
P/S3.62
P/B2.63
EPS (TTM)1.70
EPS (Forward)2.24
52W Range
36.3696% of range38.92
52W High38.92 EUR
52W Low36.36 EUR
Profitability
Gross Margin62.18%
Oper. Margin26.32%
EBITDA Margin34.96%
Profit Margin20.33%
ROE11.25%
ROA6.76%
Growth
Revenue Growth0.30%
Earnings Growth13.60%
Cash Flow & Leverage
Operating CF711.22M $
CapEx (TTM)225.14M $
FCF Margin17.75%
FCF Yield4.66%
Net Debt935.00M $
Net Debt/EBITDA1.17
Balance Sheet
Debt/Equity0.48
Current Ratio2.85
Quick Ratio2.05
Book Value/Sh14.01 EUR
Cash/Share3.843 EUR
Dividends
Fwd Div Rate0.3100 EUR
Trail. Div Rate0.3630 EUR
Div. Yield0.83%
5Y Avg Yield—
Payout Ratio17.79%
Ex-Div DateJul 7, 2026
Pay Date—
Splits
Last Split19:20
Split DateJan 8, 2026
Analyst Consensus
Rating2.4 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)38.87 EUR
Upside (mean)+0.1%
Target Range32.00 EUR – 42.11 EUR
€32.00+0.1% to mean€42.11
# Analysts7
Ownership
Shares Out.206.50M
Float205.13M
Insiders0.48%
Institutions80.23%
Technical
SMA 5035.03 (+10.8%)
SMA 20037.14 (+4.5%)
Beta0.62
S&P 52W Chg20.80%
Avg Vol (30d)567.00K
Avg Vol (10d)608.24K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—